PMID- 31630372
OWN - NLM
STAT- MEDLINE
DCOM- 20200529
LR  - 20200529
IS  - 2520-8721 (Electronic)
IS  - 1109-3099 (Linking)
VI  - 18
IP  - 4
DP  - 2019 Dec
TI  - A year in type 2 diabetes mellitus: 2018 review based on the Endorama lecture.
PG  - 401-408
LID - 10.1007/s42000-019-00139-z [doi]
AB  - The aim of this article is to review and present the most important studies 
      published in the field of type 2 diabetes mellitus (T2DM) during 2018. These 
      studies were presented in a lecture given on this topic at the Endorama Meeting 
      in Patras, Greece, in January 2019. In order to identify the most important and 
      relevant articles, a search in the English language was conducted in PubMed for 
      publications up to the end of December 2018, with special attention paid to 
      publications in high impact factor journals. The highlights of the main Diabetes 
      Meetings [ADA (American Diabetes Association) and EASD (European Association of 
      Diabetes)], as well as Medscape, were also reviewed. Last but not least, press 
      releases regarding advances in the diagnosis and treatment of T2DM were 
      considered. We finally selected and discussed important studies concerning 
      diagnosis, pathophysiology, and management of this very common clinical entity 
      (19 studies). The majority of studies were clinical trials dealing with new 
      therapeutic tools for treatment of the disease, with the greatest focus being on 
      GLP-1RA. We also presented in brief the main points of new guidelines published 
      for T2DM by various scientific societies (3 sets of guidelines). During 2018, not 
      only leading diabetes associations published guidelines on the disease, but also 
      societies belonging to other primary scientific fields. This is indicative of the 
      awareness of physicians and scientists that T2DM constitutes today a major health 
      problem and of the need for public health strategies for its treatment and 
      prevention.
FAU - Paschou, Stavroula A
AU  - Paschou SA
AUID- ORCID: 0000-0002-0651-1376
AD  - Division of Endocrinology and Diabetes, "Aghia Sophia" Hospital, Medical School, 
      National and Kapodistrian University of Athens, Athens, Greece. 
      s.a.paschou@gmail.com.
FAU - Alexandrides, Theodoros
AU  - Alexandrides T
AD  - Department of Endocrinology, University Hospital, Medical School, University of 
      Patras, Rio, Patras, Greece.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20191019
PL  - Switzerland
TA  - Hormones (Athens)
JT  - Hormones (Athens, Greece)
JID - 101142469
RN  - 0 (Hypoglycemic Agents)
SB  - IM
MH  - Diabetes Mellitus, Type 2/*therapy
MH  - Humans
MH  - Hypoglycemic Agents/administration & dosage/*therapeutic use
OTO - NOTNLM
OT  - 2018
OT  - DPP-4i
OT  - GLP-1RA
OT  - Guidelines
OT  - Insulin
OT  - Metformin
OT  - SGLT-2i
OT  - Type 2 diabetes mellitus
EDAT- 2019/10/21 06:00
MHDA- 2020/05/30 06:00
CRDT- 2019/10/21 06:00
PHST- 2019/07/12 00:00 [received]
PHST- 2019/09/22 00:00 [accepted]
PHST- 2019/10/21 06:00 [pubmed]
PHST- 2020/05/30 06:00 [medline]
PHST- 2019/10/21 06:00 [entrez]
AID - 10.1007/s42000-019-00139-z [pii]
AID - 10.1007/s42000-019-00139-z [doi]
PST - ppublish
SO  - Hormones (Athens). 2019 Dec;18(4):401-408. doi: 10.1007/s42000-019-00139-z. Epub 
      2019 Oct 19.